Jay Lichter – Think Piece

Published on
November 24th, 2015
Topic
US Economy
Duration
14 minutes
Asset class
Equities

Jay Lichter – Think Piece

Featuring Jay Lichter

Published on: November 24th, 2015 • Duration: 14 minutes • Asset Class: Equities • Topic: US Economy

Jay Lichter, Managing Director of Avalon Ventures provides honest insight into the Biotech industry and shares his concerns on the politicization of drug pricing and discusses the risks with investing in the biotech market.

Comments

  • FT
    Frank T.
    9 January 2016 @ 18:33
    I do enjoy seeing STEM educated people take on economics. There is always an over reaction to news on the Street. Not to mention the brain drain by the private sector; foreign disparity in pricing.
  • FT
    Frank T.
    9 January 2016 @ 18:19
    We certainly have to see taxpayer money was used to map the fruit fly, which has so much in common with the human genome. Then the healthcare market is so distorted by the K Street payola machine.
  • RL
    Roel L.
    3 December 2015 @ 18:54
    Big pharma is squeezing the health system
  • AC
    Andrew C.
    29 November 2015 @ 03:28
    Fantastic interview with some great general investing tips. Thanks. What's the diff b/n biotech and big pharma (no such thing as a dumb question)?
  • CL
    Chewy L.
    26 November 2015 @ 11:04
    Great insights. It would have been interesting to know his take in VRX
  • GT
    Graham T.
    25 November 2015 @ 18:26
    Outstanding. Thank you Milton.
  • CP
    Charles P.
    24 November 2015 @ 16:11
    I love these segments reflecting smart thinking about bio tech and technology. Would enjoy seeing more viewpoints from Silicon Valley, and thoughts about emerging tech.
  • WM
    Will M.
    24 November 2015 @ 15:58
    I was better educated through watching this segment. Its all too easy to slam big pharma for drug pricing, however, they have to make back their investment and some profit or why bother at all.